NB-PP_1170x120

Consumer Healthcare Products Association (CHPA)

Survey shows teen misuse of O-T-C cough medicine remains very low

Survey shows teen misuse of O-T-C cough medicine remains very low

WASHINGTON — The 2018 results from the National Institute on Drug Abuse (NIDA) and University of Michigan’s annual drug abuse survey, Monitoring the Future, were released today showing that the percentage of teens using over-the-counter (O-T-C) cough medicine containing dextromethorphan (DXM) to get high remains at 3 %. When first reported in 2006, the number of teens abusing O-T-C cough medicines

CHPA welcomes new board members

CHPA welcomes new board members

WASHINGTON — New members of the Consumer Healthcare Products Association (CHPA) board of directors were elected at the association’s fall meeting, held November 14, in New York City. Gary Downing, chief executive officer, Clarion Brands, continues serving as CHPA’s board chairman. Newly elected CHPA board members at this meeting include: Paul Gama, vice president, North America

CHPA issues statement on OTC eligibility in FSA/HSA accounts

CHPA issues statement on OTC eligibility in FSA/HSA accounts

WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement regarding OTC Eligibility in FSA/HSA Accounts: “CHPA congratulates Representatives Lynn Jenkins (R, Kan.), Ron Kind (D, Wis.), and Grace Meng (D, N.Y.) on the House of Representatives’ passage of H.R. 6199, legislation that will restore consumers’ ability to use their Health Savings Accounts

CHPA bullish on pending revision of O-T-C monograph policy

CHPA bullish on pending revision of O-T-C monograph policy

WASHINGTON — The stage is set for a regulatory change that will boost innovation by consumer health care products manufacturers, according to leaders of their association. The Food and Drug Administration’s O-T-C monograph system, which hasn’t been updated for over 45 years, is facing massive modernization efforts in the form of pending legislation in both

Retail evolution bodes well for nonprescription meds

Retail evolution bodes well for nonprescription meds

WASHINGTON — Changes on the retail scene bode well for the consumer health care products market because they show that chains are trying to stay engaged with their customers, says Consumer Healthcare Products Association (CHPA) chairman and Clarion Brands chief executive officer Gary Downing. “From our perspective it would be more concerning if they were